Background
Edited by: Agnes Szilagyi, Semmelweis University, HungaryReviewed by: Morayma Reyes-Gil, Montefiore Medical Center, United States; Giuseppe Remuzzi, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy†These authors share senior authorshipConestat alfa (ConA), a recombinant human C1 inhibitor, may prevent thromboinflammation.